Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Varner

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Microvascular Research|June 21, 2002
The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formationYoshikazu Aoka, Frances L Johnson, Kalyani Penta, et al.
Plos One|October 12, 2012
The primacy of β1 integrin activation in the metastatic cascadeHisashi Kato, Zhongji Liao, John V Mitsios, et al.
Plos One|May 15, 2015
Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low NeuroblastomaShanique A Young, Katelyn E McCabe, Alena Bartakova, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.
Cancer Research|April 15, 2010
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasisBarbara Garmy-Susini, Christie J Avraamides, Michael C Schmid, et al.
Cancer Research|July 19, 2002
Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of actionEmmanuel A Ojo-Amaize, Emeka J Nchekwube, Howard B Cottam, et al.
Blood|January 25, 2024
PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathwayHao Gu, Chiqi Chen, Zhi-Shuai Hou, et al.
Science (New York, N.Y.)|June 20, 2024
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Microvascular Research|June 21, 2002
The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formationYoshikazu Aoka, Frances L Johnson, Kalyani Penta, et al.
Plos One|October 12, 2012
The primacy of β1 integrin activation in the metastatic cascadeHisashi Kato, Zhongji Liao, John V Mitsios, et al.
Plos One|May 15, 2015
Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low NeuroblastomaShanique A Young, Katelyn E McCabe, Alena Bartakova, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.
Cancer Research|April 15, 2010
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasisBarbara Garmy-Susini, Christie J Avraamides, Michael C Schmid, et al.
Cancer Research|July 19, 2002
Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of actionEmmanuel A Ojo-Amaize, Emeka J Nchekwube, Howard B Cottam, et al.
Blood|January 25, 2024
PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathwayHao Gu, Chiqi Chen, Zhi-Shuai Hou, et al.
Science (New York, N.Y.)|June 20, 2024
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Pageof 5